Business Description
Gujarat Terce Laboratories Ltd
ISIN : INE499G01013
Share Class Description:
BOM:524314: Shs DematerialisedTotal Employee Number:
244Compare
Compare
Traded in other countries / regions
524314.India IPO Date
1994-04-07Description
Gujarat Terce Laboratories Ltd is an Indian company having business in the medical and pharmaceutical preparations. It is engaged in the manufacturing of tablets, capsules, syrup, and injections. It offers branded as well as generic formulations covering different therapeutic areas such as antibiotics, respiratory, nutraceuticals, gastrointestinal, antifungal, and many more. Some of the main brands are Acolate, Tynol, DFS, Resplash, Aziter, and others.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3.25 | |||||
Equity-to-Asset | 0.4 | |||||
Debt-to-Equity | 0.13 | |||||
Debt-to-EBITDA | 0.36 | |||||
Interest Coverage | 18.53 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.64 | |||||
Beneish M-Score | -2.22 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Book Growth Rate | 10.5 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 48.7 | |||||
9-Day RSI | 49.78 | |||||
14-Day RSI | 49.66 | |||||
3-1 Month Momentum % | -6.92 | |||||
6-1 Month Momentum % | -23.26 | |||||
12-1 Month Momentum % | -28.61 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.32 | |||||
Quick Ratio | 0.98 | |||||
Cash Ratio | 0.38 | |||||
Days Inventory | 77.33 | |||||
Days Sales Outstanding | 41.75 | |||||
Days Payable | 66.12 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.6 | |||||
Shareholder Yield % | 0.49 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 63.91 | |||||
Operating Margin % | 7.01 | |||||
Net Margin % | 4.68 | |||||
EBITDA Margin % | 7.68 | |||||
FCF Margin % | 3.55 | |||||
OCF Margin % | 3.61 | |||||
ROE % | 27.73 | |||||
ROA % | 9.28 | |||||
ROIC % | 12.61 | |||||
3-Year ROIIC % | -130.25 | |||||
ROC (Joel Greenblatt) % | 90.21 | |||||
ROCE % | 27.84 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 12.16 | |||||
PE Ratio without NRI | 10.81 | |||||
Price-to-Owner-Earnings | 34.61 | |||||
PS Ratio | 0.56 | |||||
PB Ratio | 2.74 | |||||
Price-to-Tangible-Book | 2.75 | |||||
Price-to-Free-Cash-Flow | 15.35 | |||||
Price-to-Operating-Cash-Flow | 15.08 | |||||
EV-to-EBIT | 7.39 | |||||
EV-to-EBITDA | 6.52 | |||||
EV-to-Revenue | 0.5 | |||||
EV-to-FCF | 14.41 | |||||
Price-to-Projected-FCF | 2.41 | |||||
Price-to-Median-PS-Value | 1.63 | |||||
Price-to-Graham-Number | 1.15 | |||||
Earnings Yield (Greenblatt) % | 13.54 | |||||
FCF Yield % | 6.31 | |||||
Forward Rate of Return (Yacktman) % | 11.76 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Gujarat Terce Laboratories Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 474.727 | ||
| EPS (TTM) (₹) | 2.82 | ||
| Beta | 1.2665 | ||
| 3-Year Sharpe Ratio | 0.29 | ||
| 3-Year Sortino Ratio | 0.53 | ||
| Volatility % | 42.96 | ||
| 14-Day RSI | 49.66 | ||
| 14-Day ATR (₹) | 2.155478 | ||
| 20-Day SMA (₹) | 34.121 | ||
| 12-1 Month Momentum % | -28.61 | ||
| 52-Week Range (₹) | 29 - 59.78 | ||
| Shares Outstanding (Mil) | 7.79 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Gujarat Terce Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Gujarat Terce Laboratories Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Gujarat Terce Laboratories Ltd Frequently Asked Questions
What is Gujarat Terce Laboratories Ltd(BOM:524314)'s stock price today?
The current price of BOM:524314 is ₹34.30. The 52 week high of BOM:524314 is ₹59.78 and 52 week low is ₹29.00.
When is next earnings date of Gujarat Terce Laboratories Ltd(BOM:524314)?
The next earnings date of Gujarat Terce Laboratories Ltd(BOM:524314) is .
Does Gujarat Terce Laboratories Ltd(BOM:524314) pay dividends? If so, how much?
Gujarat Terce Laboratories Ltd(BOM:524314) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Gujarat Terce Laboratories Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers